Engineered Extracellular Vesicles As a New Delivery Platform for Migraine.
A framework for pathophysiology-informed technology by first discussing the role of native EVs in promoting the migraine cascade to identify specific sites of therapeutic intervention and the critical analytical and manufacturing sciences needed to translate such engineered EVs from bench to bedside are introduced.